Koers Kaneh Bosm Biotechnology Inc Canadian Securities Exchange
Aandelen
CA4841902022
Drugshandelaren
Omzet 2018 | - | Omzet 2019 | - | Marktkapitalisatie | 13,23 mln. 18,07 mln. 12,35 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | - 0 0 | Nettowinst (verlies) 2019 | -60 mln. -81,94 mln. -56 mln. | EV/omzet 2018 * | - |
Nettoliquiditeiten 2018 * | - 0 0 | Nettoliquiditeiten 2019 * | - 0 0 | EV/omzet 2019 * | - |
K/w-verhouding 2018 * |
-
| K/w-verhouding 2019 * |
-
| Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 * |
-
| Vrij verhandelbaar | 0% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Shpilt
CEO | Chief Executive Officer | - | 15-04-19 |
Eugene Beukman
BRD | Director/Board Member | 64 | 27-04-18 |
Corporate Officer/Principal | - | 25-04-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Eugene Beukman
BRD | Director/Board Member | 64 | 27-04-18 |
Matthew Fish
BRD | Director/Board Member | - | 29-05-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,69% | 2,98 mld. | |
-15,65% | 1,27 mld. | |
+53,28% | 541 mln. | |
-12,73% | 436 mln. | |
+41,78% | 183 mln. | |
-4,60% | 93,65 mln. | |
-30,86% | 73,4 mln. | |
+37,08% | 54,57 mln. |